Crossmark

Spanlastics-Loaded Buccal Films for Improved Olmesartan Delivery and Sustained Hypertension Management: Formulation, Statistical Optimization, In Vitro and In Vivo Evaluation

Crossref DOI link: https://doi.org/10.1007/s12247-025-10347-3

Published Online: 2026-01-29

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abd Elrady, Amira N.

Elkhatib, Mona M.

Mohamed, Magdy I.

Fatouh, Ahmed M.
Funding

Funding for this research was provided by:

Cairo University
License Information

Text and Data Mining valid from 2026-01-29

Version of Record valid from 2026-01-29
More Information

Article History

Received: 30 August 2025

Accepted: 21 December 2025

First Online: 29 January 2026

Declarations

:

: All institutional and national guidelines for the care and use of laboratory animals were followed. The in vivo study protocol was approved by the Institutional Animal Ethics Committee (approval no. PI 3675). All animal experiments were conducted in accordance with the ARRIVE guidelines and the EU Directive 2010/63/EU for animal experiments.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below